Novo Nordisk is the first drugmaker to introduce a highly effective weight-loss drug, Wegovy, at a time of record obesity rates.

Lars Fruergaard Jørgensen, CEO of Novo Nordisk, discusses with Reuters Breakingviews columnist Aimee Donnellan the challenge of rapidly ramping up production of Wegovy to meet soaring demand for the breakthrough drug.
 
#LarsFruergaardJørgensen #NovoNordisk #Wegovy AimeeDonnellan #ReutersNewsmaker #Reuters #Live #News #business #finance